Researchers & Healthcare Professionals

Translational Research Program

The Translational Research Program (TRP) puts you on the bench-to-bedside fast track when it comes to finding better treatment and cures for leukemia, lymphoma and myeloma.

The Leukemia & Lymphoma Society (LLS) funds new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application. The goal of translational research is to reduce the time between laboratory findings and actual treatment.

SPECIAL NOTE: The Quality of Life (QOL) Research Funding Initiative will no longer be a component of the TRP funding mechanism. We are currently developing a stand alone program dealing with quality of life and survivorship issues, and we will announce the program launch date as soon as possible.


*Please pay special attention to our revised Guidelines and Instructions, Guidelines and Instructions for RENEWAL applications and our new RFP Announcement as they have all been revised. 


Limited to a maximum of $200,000, which includes direct costs and a maximum overhead of $19,982 or 11.1 percent of direct costs per year for three years. Budget requests should be carefully justified and commensurate with the project's needs.

Application Renewal

An additional two years if it includes an approved clinical trial and a fully justified research plan. One of the program's principal intents is to permit the acquisition of sufficient data to apply to an appropriate agency or sponsor for sustained support.


Letter of intent due 3 p.m. ET, February 18*

Full application due 3 p.m. ET, March 1

*The Letter of Intent submission deadline has been changed to Tuesday, February 18th due to the President's Day holiday.

How to Apply

LLS uses its own Research Portal powered by FLUXX for electronic preliminary and full application submission.

  • Before you submit your letter of intent and application, download and read TRP Guidelines & Instructions for New Letter of Intent & Full Application.
  • Before you apply, log in to FLUXX and register. Grants and contract officials must also register your institution.
  • Submit an online letter of intent via FLUXX by 3 p.m. ET, February 18.
  • Submit a full online application via FLUXX by 3 p.m. ET, March 1.

If you submitted a proposal and developed a profile with LLS in the past, you (and your institution) still need to validate your account and create a new password in FLUXX. If you have any technical difficulties with FLUXX, please contact us via e-mail at

Need More Information?

Director of Research Administration
The Leukemia & Lymphoma Society
1311 Mamaroneck Ave.White Plains, NY 10605
(914) 821-8301

last updated on Friday, November 21, 2014

Why LLS?

Your gift will be used to fund vital research and support our patient and community services.

Questions? Contact us.



A free resource provided by the National Institutes of Health - access more than 20 million biomedical literature citations.

Learn More